|
시장보고서
상품코드
2070370
뇌파 측정(EEG) 기기 시장 : 규모, 점유율, 성장, 업계 분석, 지역 인사이트 및 예측(2026-2034년)Electroencephalography Devices Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
뇌파 측정(EEG) 기기 시장의 성장 요인
세계 뇌파 측정(EEG) 시장 규모는 2025년 15억 3,000만 달러로 평가되었고, 2026년 16억 4,000만 달러에서 2034년까지 31억 7,000만 달러로 성장할 것으로 예상되며, 예측 기간 동안 연평균 성장률(CAGR)은 8.4%에 달할 전망입니다. 뇌파(EEG) 장치는 뇌의 전기적 활동을 기록하고 모니터링하기 위해 사용되는 비침습적 진단 시스템으로, 간질, 뇌종양, 수면장애, 뇌증, 외상성 뇌손상 등의 신경 질환 진단에 도움이 됩니다.
시장 성장은 신경 질환 유병률 증가, 조기 진단에 대한 인식 제고, 의료 인프라 확충, 그리고 휴대용·웨어러블형 뇌파(EEG) 시스템의 기술적 발전에 힘입어 이루어지고 있습니다. 또한, 인공지능(AI), 클라우드 컴퓨팅, 원격 모니터링 기술의 통합을 통해 뇌파(EEG) 진단은 혁신을 이루며 임상 효율이 향상되고 있습니다.
2025년에는 북미가 세계 시장을 주도하며, 시장 총매출의 33.33%를 차지했습니다.
뇌파 측정(EEG) 기기 시장 동향
AI와 클라우드 기반 뇌파(EEG) 분석의 통합
뇌파 측정(EEG) 기기 시장에서 가장 중요한 동향 중 하나는 AI를 활용한 분석 기술과 클라우드 기반 플랫폼의 통합이 진행되고 있다는 점입니다. 이러한 기술을 통해 발작 감지가 자동화되고, 소견 판정 시간이 단축되며, 진단 정확도가 향상되고, 환자 데이터에 대한 원격 접근이 가능해집니다. 의료 서비스 제공업체들은 업무 흐름을 효율화하고 환자의 예후를 개선하기 위해 지능형 뇌파 솔루션을 점점 더 많이 도입하고 있습니다.
2024년 11월, 일본광전 주식회사는 Ad-Tech Medical의 모회사인 NeuroAdvanced Corp.의 지분 71.4%를 인수했습니다. 이는 첨단 뇌파(EEG) 시스템과 특수한 두개내 전극 기술을 결합하여 간질 진단을 강화하는 것을 목적으로 합니다.
시장 성장 촉진요인
신경계 질환 유병률 증가
간질, 알츠하이머병, 치매, 파킨슨병, 수면장애 등 신경계 질환의 발병률 증가는 시장 성장을 이끄는 주요 요인입니다. 뇌파검사(EEG)는 뇌 기능을 평가하고 신경 질환의 상태를 모니터링하기 위한 가장 효과적인 진단 도구 중 하나로 자리매김하고 있습니다.
세계보건기구(WHO)에 따르면, 매년 약 500만 명이 간질 진단을 받고 있으며, 2024년 기준으로 전 세계적으로 약 5,000만 명이 간질을 앓으며 생활하고 있습니다. 또한, 신경 질환에 걸리기 쉬운 고령 인구가 증가함에 따라 병원 및 외래 진료 현장에서 뇌파 진단에 대한 수요가 더욱 높아지고 있습니다.
시장 성장 억제요인
장비의 높은 비용과 숙련된 인력의 필요성
기술의 발전에도 불구하고, 첨단 뇌파(EEG) 시스템의 높은 비용이 특히 소규모 의료시설이나 개발도상 지역에서 도입의 걸림돌로 작용하고 있습니다. AI가 탑재된 EEG 장치나 채널 수가 많은 EEG 장치에는 막대한 투자와 지속적인 유지보수가 필요합니다.
2026년 3월에 발표된 LabXNew의 데이터에 따르면, EEG 및 EMG 시스템의 가격은 복잡성, 채널 수, 휴대성, 소프트웨어 기능에 따라 일반적으로 2만 달러에서 15만 달러 사이입니다. 또한, 뇌파(EEG) 분석에는 고도의 훈련을 받은 신경과 전문의나 기술자가 필요하지만, 많은 국가에서 숙련된 전문가의 부족이 여전히 큰 과제로 남아 있습니다.
시장 기회
휴대용 및 웨어러블형 뇌파(EEG) 기기의 성장
휴대용 및 웨어러블형 뇌파(EEG) 기술의 급속한 발전은 큰 성장 기회를 가져오고 있습니다. 이러한 시스템은 기존의 임상 환경 이외의 장소에서도 지속적인 뇌 모니터링을 가능하게 하여, 원격 의료, 재택치료 및 원격 환자 모니터링을 실현합니다.
소형 무선 뇌파(EEG) 기기의 혁신은 접근성 향상과 환자 편의성 증진에 기여하고 있습니다. 예를 들어, 성균관대학교 연구진은 문신과 같은 전극을 사용하여 지속적이고 고품질의 뇌 활동 모니터링을 가능하게 하는 무선 이어폰형 EEG 장치를 개발했습니다.
시장의 과제
데이터의 복잡성과 표준화의 부재
뇌파(EEG) 데이터의 관리와 해석은 여전히 큰 과제로 남아 있습니다. 뇌파(EEG) 기록에서는 방대한 양의 복잡한 정보가 생성되므로, 정확한 분석을 위해서는 표준화된 프로토콜이 필요합니다. 전극 배치, 데이터 형식, 보고 방식의 차이는 진단의 일관성에 영향을 미칠 수 있습니다.
게다가 많은 의료 기관에서는 대규모 뇌파(EEG) 데이터 세트를 효율적으로 관리·분석하는 데 필요한 IT 인프라가 갖춰져 있지 않아 운영상의 문제가 발생하고 있으며, 이로 인해 보다 광범위한 도입이 저해되고 있습니다.
지역별 분석
북미
북미는 여전히 최대의 지역 시장으로, 2024년 4억 8,000만 달러에서 증가하여 2025년에는 5억 1,000만 달러에 달할 것으로 전망됩니다. 견조한 의료비 지출, 유리한 환급 정책, 그리고 첨단 신경 진단법의 도입 확대가 시장 성장을 뒷받침하고 있습니다.
미국의 EEG 기기 시장은 2026년에 4억 7,000만 달러에 달해, 이는 세계 시장 매출의 약 28.6%를 차지할 것으로 전망됩니다.
유럽
유럽은 예측 기간 동안 연평균 성장률(CAGR) 7.8%를 나타낼 것으로 전망됩니다. 신경학 분야의 연구 활동 활성화, 인구 고령화, 그리고 지원적인 의료 정책이 시장 확대에 기여하고 있습니다.
- 영국(2026년) : 8,000만 달러
- 독일(2026년) : 9,000만 달러
아시아태평양
아시아태평양은 2026년에 4억 3,000만 달러에 달하고, 2위 시장이 될 것으로 예측됩니다. 이러한 성장은 의료 인프라의 개선, 신경 질환에 대한 인식 제고, 그리고 신경과학 연구에 대한 투자 확대에 힘입어 이루어지고 있습니다.
2026년 주요 국가의 전망은 다음과 같습니다.
- 중국: 1억 4,000만 달러
- 일본: 1억 2,000만 달러
- 인도: 8,000만 달러
라틴아메리카, 중동 및 아프리카
이 지역들에서는 신경계 질환 진단 서비스에 대한 접근성이 개선되고 주요 제조업체들의 투자가 증가함에 따라 완만한 성장이 예상됩니다.
- 라틴아메리카 시장(2026년) : 3억 4,000만 달러
- GCC 시장(2026년) : 5,000만 달러
목차
제1장 서론
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 뇌파 측정(EEG) 기기 시장 분석, 인사이트 및 예측(2021-2034년)
제6장 북미 뇌파 측정(EEG) 기기 시장 분석, 인사이트 및 예측(2021-2034년)
제7장 유럽 뇌파 측정(EEG) 기기 시장 분석, 인사이트 및 예측(2021-2034년)
제8장 아시아태평양 뇌파 측정(EEG) 기기 시장 분석, 인사이트 및 예측(2021-2034년)
제9장 라틴아메리카 뇌파 측정(EEG) 기기 시장 분석, 인사이트 및 예측(2021-2034년)
제10장 중동 및 아프리카 뇌파 측정(EEG) 기기 시장 분석, 인사이트 및 예측(2021-2034년)
제11장 경쟁 분석
JHS 26.07.01Growth Factors of Electroencephalography (EEG) Devices Market
The global Electroencephalography (EEG) Devices Market was valued at USD 1.53 billion in 2025 and is projected to grow from USD 1.64 billion in 2026 to USD 3.17 billion by 2034, registering a CAGR of 8.4% during the forecast period. EEG devices are non-invasive diagnostic systems used to record and monitor electrical activity in the brain, helping diagnose neurological conditions such as epilepsy, brain tumors, sleep disorders, encephalopathies, and traumatic brain injuries.
Market growth is being driven by the rising prevalence of neurological disorders, increasing awareness regarding early diagnosis, expanding healthcare infrastructure, and technological advancements in portable and wearable EEG systems. Furthermore, the integration of artificial intelligence (AI), cloud computing, and remote monitoring technologies is transforming EEG diagnostics and improving clinical efficiency.
North America dominated the global market in 2025, accounting for 33.33% of total market revenue.
Electroencephalography (EEG) Devices Market Trends
Integration of AI and Cloud-Based EEG Analytics
One of the most significant trends in the EEG devices market is the growing integration of AI-powered analytics and cloud-based platforms. These technologies automate seizure detection, reduce interpretation time, improve diagnostic accuracy, and enable remote access to patient data. Healthcare providers are increasingly adopting intelligent EEG solutions to streamline workflows and enhance patient outcomes.
In November 2024, Nihon Kohden Corporation acquired a 71.4% stake in NeuroAdvanced Corp., the parent company of Ad-Tech Medical, to strengthen epilepsy diagnostics by combining advanced EEG systems with specialized intracranial electrode technologies.
Market Drivers
Rising Prevalence of Neurological Disorders
The increasing incidence of neurological diseases such as epilepsy, Alzheimer's disease, dementia, Parkinson's disease, and sleep disorders is a major factor driving market growth. EEG remains one of the most effective diagnostic tools for evaluating brain function and monitoring neurological conditions.
According to the World Health Organization (WHO), approximately 5 million people are diagnosed with epilepsy every year, while nearly 50 million individuals worldwide were living with epilepsy as of 2024. Additionally, the growing geriatric population, which is more susceptible to neurological disorders, is further increasing demand for EEG diagnostics across hospitals and outpatient settings.
Market Restraints
High Equipment Cost and Skilled Workforce Requirements
Despite technological advancements, the high cost of advanced EEG systems continues to limit adoption, especially in smaller healthcare facilities and developing regions. AI-enabled and high-channel EEG devices require substantial investment and ongoing maintenance.
According to LabXNew data published in March 2026, EEG and EMG systems generally cost between USD 20,000 and USD 150,000, depending on complexity, channel count, portability, and software capabilities. Additionally, EEG interpretation requires highly trained neurologists and technicians, and shortages of skilled professionals remain a significant challenge in many countries.
Market Opportunities
Growth of Portable and Wearable EEG Devices
The rapid development of portable and wearable EEG technologies presents substantial growth opportunities. These systems support continuous brain monitoring outside traditional clinical environments, enabling telemedicine, home healthcare, and remote patient monitoring.
Innovations in compact and wireless EEG devices are helping improve accessibility and patient convenience. For example, researchers at Sungkyunkwan University developed a wireless earbud-style EEG device that uses tattoo-like electrodes to provide continuous, high-quality brain activity monitoring.
Market Challenges
Data Complexity and Lack of Standardization
Managing and interpreting EEG data remains a significant challenge. EEG recordings generate large volumes of complex information that require standardized protocols for accurate analysis. Variations in electrode placement, data formats, and reporting methods can affect diagnostic consistency.
Additionally, many healthcare facilities lack the IT infrastructure needed to manage and analyze large EEG datasets efficiently, creating operational challenges and limiting broader adoption.
Segment Analysis
By Product Type
The EEG Accessories & Consumables segment dominated the market in 2025. Increasing adoption of wireless and home-based EEG systems is generating strong demand for electrodes, caps, gels, sensors, and disposable accessories that enhance patient convenience and hygiene.
The EEG Systems segment is projected to grow at a CAGR of 7.5% during the forecast period due to increasing installations of advanced diagnostic equipment across healthcare facilities.
By Application
The Epilepsy Diagnosis & Monitoring segment accounted for the largest market share in 2025 and is projected to hold 41.4% of the market in 2026. EEG remains the gold-standard diagnostic tool for detecting abnormal brain activity associated with seizures and epilepsy.
The Sleep Disorder Diagnosis segment is expected to grow at a CAGR of 7.8%, supported by rising awareness and diagnosis of sleep-related neurological conditions.
By End User
The Hospitals & Clinics segment dominated the market in 2025 and is expected to account for 65.0% market share in 2026. Increasing establishment of neurology departments and specialized neuroscience centers is driving demand for advanced EEG monitoring systems.
Meanwhile, the Diagnostic Centers & EEG Labs segment is projected to grow at a CAGR of 9.2% during the forecast period.
Regional Analysis
North America
North America remained the largest regional market, reaching USD 0.51 billion in 2025, up from USD 0.48 billion in 2024. Strong healthcare expenditure, favorable reimbursement policies, and growing adoption of advanced neurological diagnostics are supporting market growth.
The U.S. EEG Devices Market is projected to reach USD 0.47 billion in 2026, accounting for approximately 28.6% of global market revenue.
Europe
Europe is expected to grow at a CAGR of 7.8% during the forecast period. Increasing neurological research activities, aging populations, and supportive healthcare policies are contributing to market expansion.
- United Kingdom (2026): USD 0.08 billion
- Germany (2026): USD 0.09 billion
Asia Pacific
Asia Pacific is expected to become the second-largest market, reaching USD 0.43 billion in 2026. Growth is being driven by improving healthcare infrastructure, increasing awareness of neurological disorders, and growing investments in neuroscience research.
Key country forecasts for 2026 include:
- China: USD 0.14 billion
- Japan: USD 0.12 billion
- India: USD 0.08 billion
Latin America and Middle East & Africa
These regions are expected to witness moderate growth due to improving access to neurological diagnostic services and increasing investments by leading manufacturers.
- Latin America Market (2026): USD 0.34 billion
- GCC Market (2026): USD 0.05 billion
Competitive Landscape
The global EEG devices market is highly competitive, with major companies focusing on AI integration, cloud connectivity, wearable technologies, and strategic acquisitions to strengthen their market positions.
Key companies operating in the market include:
- Natus Medical, Inc.
- Medtronic
- Nihon Kohden Corporation
- Brain Products GmbH
- Neurosoft
- Compumedics Limited
- Mitsar Co., LTD.
- Micromed
- Cadwell Laboratories, Inc.
- ANT Neuro
These companies continue to invest in product innovation, regulatory approvals, and healthcare partnerships to expand their market presence globally.
Key Industry Developments
- November 2025: Ceribell received FDA 510(k) clearance for its Clarity AI algorithm for seizure detection across all age groups.
- September 2025: Natus Medical acquired full ownership of Holberg EEG, strengthening its AI-based EEG capabilities.
- May 2025: Natus Medical launched BrainWatch, a point-of-care EEG solution for emergency rooms and intensive care units.
- May 2025: Emotiv introduced MW20 EEG Active Noise-Cancelling Earphones featuring AI-driven cognitive monitoring.
- October 2024: Natus Medical launched autoSCORE AI for automated clinical EEG analysis.
- April 2024: Soterix Medical introduced MxN-GO EEG, integrating HD-tES and EEG technologies for research applications.
Conclusion
The global Electroencephalography (EEG) Devices Market is poised for substantial growth, increasing from USD 1.53 billion in 2025 to USD 1.64 billion in 2026, and reaching USD 3.17 billion by 2034. Rising neurological disease prevalence, increasing demand for early diagnosis, expansion of portable and wearable EEG technologies, and growing integration of AI-powered analytics are driving market growth. While challenges such as high equipment costs, data complexity, and skilled workforce shortages persist, ongoing technological advancements and expanding healthcare investments are expected to create strong growth opportunities throughout the forecast period.
Segmentation By Product Type, Application, End-user, and Region
By Product Type * EEG Systems
- EEG Accessories & Consumables
By Application * Epilepsy Diagnosis & Monitoring
- Sleep Disorder Diagnosis
- Critical Care & Emergency Monitoring
- Intraoperative Monitoring
- Others
By End-user * Hospitals & Clinics
- Diagnostic Centers & EEG Labs
- Academic & Research Institutes
- Others
By Region * North America (By Product Type, Application, End-user, and Country)
- U.S. (Product Type)
- Canada (Product Type)
- Europe (By Product Type, Application, End-user, and Country/Sub-region)
- Germany (Product Type)
- U.K. (Product Type)
- France (Product Type)
- Spain (Product Type)
- Italy (Product Type)
- Scandinavia (Product Type)
- Rest of Europe (Product Type)
- Asia Pacific (By Product Type, Application, End-user, and Country/Sub-region)
- China (Product Type)
- Japan (Product Type)
- India (Product Type)
- Australia (Product Type)
- Southeast Asia (Product Type)
- Rest of Asia Pacific (Product Type)
- Latin America (By Product Type, Application, End-user, and Country/Sub-region)
- Brazil (Product Type)
- Mexico (Product Type)
- Rest of Latin America (Product Type)
- Middle East & Africa (By Product Type, Application, End-user, and Country/Sub-region)
- GCC (Product Type)
- South Africa (Product Type)
- Rest of Middle East & Africa (Product Type)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Conditions, by key Country/Region, 2025
- 4.2. Advancements in Electroencephalography (EEG) Devices
- 4.3. New Product Launches, by Key Players
- 4.4. Key Industry Developments - (Mergers, Acquisitions & Partnerships, etc.)
5. Global Electroencephalography (EEG) Devices Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. EEG Systems
- 5.1.2. EEG Accessories & Consumables
- 5.2. Market Analysis, Insights and Forecast - By Application
- 5.2.1. Epilepsy Diagnosis & Monitoring
- 5.2.2. Sleep Disorder Diagnosis
- 5.2.3. Critical Care & Emergency Monitoring
- 5.2.4. Intraoperative Monitoring
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals & Clinics
- 5.3.2. Diagnostic Centers & EEG Labs
- 5.3.3. Academic & Research Institutes
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Electroencephalography (EEG) Devices Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. EEG Systems
- 6.1.2. EEG Accessories & Consumables
- 6.2. Market Analysis, Insights and Forecast - By Application
- 6.2.1. Epilepsy Diagnosis & Monitoring
- 6.2.2. Sleep Disorder Diagnosis
- 6.2.3. Critical Care & Emergency Monitoring
- 6.2.4. Intraoperative Monitoring
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals & Clinics
- 6.3.2. Diagnostic Centers & EEG Labs
- 6.3.3. Academic & Research Institutes
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Product Type
- 6.4.2. Canada
- 6.4.2.1. By Product Type
- 6.4.1. U.S.
7. Europe Electroencephalography (EEG) Devices Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. EEG Systems
- 7.1.2. EEG Accessories & Consumables
- 7.2. Market Analysis, Insights and Forecast - By Application
- 7.2.1. Epilepsy Diagnosis & Monitoring
- 7.2.2. Sleep Disorder Diagnosis
- 7.2.3. Critical Care & Emergency Monitoring
- 7.2.4. Intraoperative Monitoring
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals & Clinics
- 7.3.2. Diagnostic Centers & EEG Labs
- 7.3.3. Academic & Research Institutes
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. Germany
- 7.4.1.1. By Product Type
- 7.4.2. U.K.
- 7.4.2.1. By Product Type
- 7.4.3. France
- 7.4.3.1. By Product Type
- 7.4.4. Italy
- 7.4.4.1. By Product Type
- 7.4.5. Spain
- 7.4.5.1. By Product Type
- 7.4.6. Scandinavia
- 7.4.6.1. By Product Type
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product Type
- 7.4.1. Germany
8. Asia Pacific Electroencephalography (EEG) Devices Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. EEG Systems
- 8.1.2. EEG Accessories & Consumables
- 8.2. Market Analysis, Insights and Forecast - By Application
- 8.2.1. Epilepsy Diagnosis & Monitoring
- 8.2.2. Sleep Disorder Diagnosis
- 8.2.3. Critical Care & Emergency Monitoring
- 8.2.4. Intraoperative Monitoring
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals & Clinics
- 8.3.2. Diagnostic Centers & EEG Labs
- 8.3.3. Academic & Research Institutes
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. China
- 8.4.1.1. By Product Type
- 8.4.2. India
- 8.4.2.1. By Product Type
- 8.4.3. Japan
- 8.4.3.1. By Product Type
- 8.4.4. Australia
- 8.4.4.1. By Product Type
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product Type
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product Type
- 8.4.1. China
9. Latin America Electroencephalography (EEG) Devices Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. EEG Systems
- 9.1.2. EEG Accessories & Consumables
- 9.2. Market Analysis, Insights and Forecast - By Application
- 9.2.1. Epilepsy Diagnosis & Monitoring
- 9.2.2. Sleep Disorder Diagnosis
- 9.2.3. Critical Care & Emergency Monitoring
- 9.2.4. Intraoperative Monitoring
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals & Clinics
- 9.3.2. Diagnostic Centers & EEG Labs
- 9.3.3. Academic & Research Institutes
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product Type
- 9.4.2. Mexico
- 9.4.2.1. By Product Type
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product Type
- 9.4.1. Brazil
10. Middle East & Africa Electroencephalography (EEG) Devices Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product Type
- 10.1.1. EEG Systems
- 10.1.2. EEG Accessories & Consumables
- 10.2. Market Analysis, Insights and Forecast - By Application
- 10.2.1. Epilepsy Diagnosis & Monitoring
- 10.2.2. Sleep Disorder Diagnosis
- 10.2.3. Critical Care & Emergency Monitoring
- 10.2.4. Intraoperative Monitoring
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals & Clinics
- 10.3.2. Diagnostic Centers & EEG Labs
- 10.3.3. Academic & Research Institutes
- 10.3.4. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Product Type
- 10.4.2. GCC
- 10.4.2.1. By Product Type
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Product Type
- 10.4.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Natus Medical, Inc.
- 11.2.2. Medtronic
- 11.2.3. Nihon Kohden Corporation
- 11.2.4. Brain Products GmbH
- 11.2.5. Neurosoft
- 11.2.6. Compumedics Limited
- 11.2.7. Mitsar Co., LTD.
- 11.2.8. Micromed
- 11.2.9. Cadwell Laboratories, Inc.
- 11.2.10. ANT Neuro
